Summary.
Objective: The aim of this study was to examine concentrations of levomepromazine and its metabolite desmethyl-levomepromazine in different regions of human brain and in relationship to drug-free time.
Methods: Drug concentrations were measured in up to 43 regions of 5 postmortem human brains of patients previously treated with levomepromazine. To enable statistical comparison across brain regions several smaller brain areas were put together to form larger brain areas (cortex cerebri, limbic system, cerebellum, basal ganglia, thalamus). Mean values of drug concentrations in these larger brain areas were used in a repeated measurement ANOVA to analyze for region specific distribution. The elimination half-life in brain tissue was estimated with a NONMEM population kinetic analysis using the mean value of all brain regions of an individual case.
Results: Levomepromazine and desmethyl-levomepromazine appear to accumulate in human brain tissue relative to blood. Mean concentrations differed largely between individual brains, in part due to differences in dose of drug, duration of treatment and drug-free time before death. There was an apparent region-specific difference in levomepromazine concentrations with highest values in the basal ganglia (mean 316 ng/g) and lowest values in the cortex cerebri (mean 209 ng/g). The elimination half-life from brain tissue is longer than from blood and was calculated to be about one week. Similar results were obtained with desmethyl-levomepromazine.
Conclusions: Levomepromazine shows a region-specific distribution in the human brain with highest values in the basal ganglia. This might be the consequence of low expression of the metabolic enzyme Cyp2D6 in the basal ganglia. If this finding is true also for other neuroleptic drugs it might increase our understanding of preferential toxicity of neuroleptic drugs against basal ganglia structures and higher volumes of basal ganglia of neuroleptic-treated patients. Furthermore, patients exposed to levomepromazine cannot be considered to be free of residual effects of the drug for a number of weeks after withdrawal.
Similar content being viewed by others
References
A-HM Afifi EL Way (1967) ArticleTitleEstimation of methotrimeprazine in brain and correlation of brain levels with pharmacologic activity. J Pharm Sci 56 720–724 Occurrence Handle1:CAS:528:DyaF2sXktlWiu7g%3D Occurrence Handle6039814
A-HM Afifi EL Way (1968) ArticleTitleStudies on the biologic disposition of methotrimeprazine. J Pharmacol Exp Ther 160 397–406 Occurrence Handle1:CAS:528:DyaF1cXpsVGlsg%3D%3D Occurrence Handle5647306
Allgén LG, Hellström L, Sant’Orp CJ (1963) On the metabolism and elimination of the psychotropic phenothiazine drug levomepromazine (NozinanR) in man. Acta Psychiatr Neurol Scand [Suppl 39] [Suppl 169]: 366–381
C Andersson RM Hamer CP Lawler RB Mailman JA Lieberman (2002) ArticleTitleStriatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27 143–151 Occurrence Handle10.1016/S0893-133X(02)00287-7 Occurrence Handle1:CAS:528:DC%2BD38XkvFyqtr4%3D Occurrence Handle12093588
A Bal M Smialowska (1987) ArticleTitleThe influence of some antidepressant drugs on the nuclear volume of rat cingulate cortex cells in culture. Neuroscience 22 671–674 Occurrence Handle10.1016/0306-4522(87)90362-9 Occurrence Handle1:CAS:528:DyaL1cXkvFartw%3D%3D Occurrence Handle3670604
A Bal-Klara MM Bird (1990) ArticleTitleThe effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture. Neuroscience 37 685–692 Occurrence Handle10.1016/0306-4522(90)90099-P Occurrence Handle1:CAS:528:DyaK3MXjsFyhug%3D%3D Occurrence Handle2247218
Beal SL, Sheiner LB (1992) NONMEM Users Guides, NONMEM Project Group, San Francisco. University of California, San Francisco
MR Britto PJ Wedlund (1992) ArticleTitleCytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metab Dispos 20 446–450 Occurrence Handle1:CAS:528:DyaK38Xktl2ktrc%3D Occurrence Handle1355722
MH Chakos JA Liebermann J Alvir RM Bilder M Ashtari (1995) ArticleTitleCaudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345 456–457 Occurrence Handle10.1016/S0140-6736(95)90441-7 Occurrence Handle1:STN:280:ByqC2MjgvF0%3D Occurrence Handle7853978
MH Chakos O Shirakawa J Lieberman H Lee R Bilder CA Tamminga (1998) ArticleTitleStriatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry 44 675–684 Occurrence Handle10.1016/S0006-3223(98)00029-8 Occurrence Handle1:CAS:528:DyaK1cXntlWmurw%3D Occurrence Handle9798070
BM Cohen S Babb A Campbell RJ Baldessarini (1988) ArticleTitlePersistence of haloperidol in the brain. Arch Gen Psychiatry 45 879–880 Occurrence Handle1:STN:280:BieA38rot1w%3D Occurrence Handle3415432
PW Corson P Nopoulos DD Miller S Arndt NC Andreasen (1999) ArticleTitleChange in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156 1200–1204 Occurrence Handle1:STN:280:DyaK1MznvVOmtg%3D%3D Occurrence Handle10450260
SG Dahl (1976) ArticleTitlePharmacokinetics of methotrimeprazine after single and multiple doses. Clin Pharmacol Ther 19 435–442 Occurrence Handle1:CAS:528:DyaE28XktVSisbc%3D Occurrence Handle1269194
SG Dahl (1982) ArticleTitleActive metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects. Ther Drug Monit 4 33–40 Occurrence Handle1:CAS:528:DyaL38Xks1GktLk%3D Occurrence Handle6122292
SG Dahl M Garle (1977) ArticleTitleIdentification of nonpolar methotrimeprazine metabolites in plasma and urine by GLC-mass spectrometry. J Pharm Sci 66 190–193 Occurrence Handle1:CAS:528:DyaE2sXhsFShsLg%3D Occurrence Handle839414
SG Dahl H Johnsen CR Lee (1982) ArticleTitleGas chromatographic mass spectrometric identification of O-demethylated and mono-hydroxylated metabolites of levomepromazine in blood from psychiatric patients by selected ion recording with high resolution. Biomed Mass Spectrometry 9 534–538 Occurrence Handle1:CAS:528:DyaL3sXktlalt78%3D
SG Dahl RE Strandjord S Sigfusson (1977) ArticleTitlePharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup. Eur J Clin Pharmacol 11 305–310 Occurrence Handle10.1007/BF00607681 Occurrence Handle1:CAS:528:DyaE2sXltFWiu74%3D Occurrence Handle862652
WA Daniel (2003) ArticleTitleMechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27 65–73 Occurrence Handle10.1016/S0278-5846(02)00317-2 Occurrence Handle1:CAS:528:DC%2BD3sXmsFakug%3D%3D Occurrence Handle12551728
WA Daniel J Wójcikowski (1997) ArticleTitleContribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol Toxicol 80 62–68 Occurrence Handle1:CAS:528:DyaK2sXhtlOnt70%3D Occurrence Handle9060036
WA Daniel J Wojcikowski A Palucha (2001) ArticleTitleIntracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134 807–814 Occurrence Handle10.1038/sj.bjp.0704319 Occurrence Handle1:CAS:528:DC%2BD3MXotlChsb0%3D Occurrence Handle11606321
PM Doraiswamy LA Tupler KR Krishnan (1995) ArticleTitleNeuroleptic treatment and caudate plasticity [published erratum appears in Lancet (1995) 345(8959): 1250]. Lancet 345 734–735 Occurrence Handle1:STN:280:ByqC1M7jtVw%3D Occurrence Handle7885157
AA El Ela S Härtter U Schmitt C Hiemke H Spahn-Langguth P Langguth (2004) ArticleTitleIdentification of P-glycoprotein substrates and inhibitors among psychoactive compounds – implications for pharmacokinetics of selected substrates. J Pharm Pharmacol 56 967–975 Occurrence Handle10.1211/0022357043969 Occurrence Handle1:CAS:528:DC%2BD2cXntFeisb4%3D Occurrence Handle15285840
W Gsell KW Lange R Pfeuffer S Heckers H Heinsen D Senitz K Jellinger G Ransmayr I Wichart R Vock H Beckmann P Riederer (1993) ArticleTitleHow to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39 31–70 Occurrence Handle1:STN:280:ByyA28jksFA%3D
LM Gunne JE Haggstrom B Sjoquist (1984) ArticleTitleAssociation with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309 347–349 Occurrence Handle10.1038/309347a0 Occurrence Handle1:CAS:528:DyaL2cXktFOhtbg%3D Occurrence Handle6727989
RE Gur V Maany PD Mozley C Swanson W Bilker RC Gur (1998) ArticleTitleSubcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 155 1711–1717 Occurrence Handle1:STN:280:DyaK1M%2Fls12itg%3D%3D Occurrence Handle9842780
PA Hals SG Dahl (1994) ArticleTitleEffect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat. Pharmacol Toxicol 75 255–260 Occurrence Handle1:CAS:528:DyaK2MXitFKjsLk%3D Occurrence Handle7870695
E Hara PS Reinach Q Wen P Iserovich J Fischbarg (1999) ArticleTitleFluoxetine inhibits K+ transport pathways (K+ efflux, Na+–K+–2Cl− cotransport, and Na+ pump) underlying volume regulation in corneal endothelial cells. J Membr Biol 171 75–85 Occurrence Handle10.1007/s002329900560 Occurrence Handle1:CAS:528:DyaK1MXmtVKlurc%3D Occurrence Handle10485996
S Heckers H Heinsen Y Heinsen H Beckmann (1991) ArticleTitleCortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 29 556–566 Occurrence Handle10.1016/0006-3223(91)90091-Y Occurrence Handle1:STN:280:By6B2svlslI%3D Occurrence Handle2054430
T Hilberg J Mørland A Bjørneboe (1994) ArticleTitlePostmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64 47–55 Occurrence Handle10.1016/0379-0738(94)90241-0 Occurrence Handle1:STN:280:ByuB3cfnvFI%3D Occurrence Handle8157229
EK Hoffmann LO Simonsen (1989) ArticleTitleMembrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev 69 315–382 Occurrence Handle1:STN:280:BiaC1cvovFw%3D Occurrence Handle2538851
PAJ Janssen W Soudijn I Wijngaarden A Dresse (1968) ArticleTitlePimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. III. Regional distribution of pimozide and of haloperidol in the dog brain. Arzneimittelforschung 18 282–287 Occurrence Handle1:CAS:528:DyaF1cXktVWmsbo%3D Occurrence Handle5696000
H Johnsen SG Dahl (1982) ArticleTitleIdentification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man. Drug Metab Dispos 10 63–67 Occurrence Handle1:CAS:528:DyaL38Xhslertr8%3D Occurrence Handle6124386
J Kornhuber W Retz P Riederer (1995) ArticleTitleSlow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs? J Neural Transm [Suppl] 46 311–319
J Kornhuber A Schultz J Wiltfang I Meineke CH Gleiter R Zöchling K-W Boissl F Leblhuber P Riederer (1999) ArticleTitlePersistence of haloperidol in human brain tissue. Am J Psychiatry 156 885–890 Occurrence Handle1:STN:280:DyaK1M3ovVequw%3D%3D Occurrence Handle10360127
ER Korpi JE Kleinman DT Costakos M Linnoila RJ Wyatt (1984) ArticleTitleReduced haloperidol in the post-mortem brains of haloperidol-treated patients. Psychiatry Res 11 259–269 Occurrence Handle10.1016/0165-1781(84)90074-X Occurrence Handle1:CAS:528:DyaL2cXktFKksrk%3D Occurrence Handle6587418
PM Laduron PF Janssen JE Leysen (1978) ArticleTitleSpiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. Biochem Pharmacol 27 317–321 Occurrence Handle1:CAS:528:DyaE1cXhvVagtL0%3D Occurrence Handle23127
Martindale. The Extra Pharmacapoeia (1993). In: Reynolds JEF (ed) The Pharmaceutical Press, London, pp xxi–xxv
UA Meyer R Amrein LP Balant L Bertilsson M Eichelbaum TW Guentert S Henauer P Jackson G Laux H Mikkelsen C Peck BG Pollock R Priest F Sjöqvist A Delini-Stula (1996) ArticleTitleAntidepressants and drug-metabolizing enzymes – expert group report. Acta Psychiatr Scand 93 71–79 Occurrence Handle1:CAS:528:DyaK28Xitl2htbY%3D Occurrence Handle8686486
DD Miller NC Andreasen DS O’Leary K Rezai GL Watkins LL Ponto RD Hichwa (1997a) ArticleTitleEffect of antipsychotics on regional cerebral blood flow measured with positron emission tomography [published erratum appears in Neuropsychopharmacology (1998) 18(4): 323–324]. Neuropsychopharmacology 17 230–240 Occurrence Handle10.1016/S0893-133X(97)00042-0 Occurrence Handle1:CAS:528:DyaK2sXms1SjsLo%3D
DD Miller K Rezai R Alliger NC Andreasen (1997b) ArticleTitleThe effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99 m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry 41 550–559 Occurrence Handle10.1016/S0006-3223(96)00110-2 Occurrence Handle1:CAS:528:DyaK2sXitVaksrs%3D
E Morel KG Lloyd SG Dahl (1987) ArticleTitleAnti-apomorphine effects of phenothiazine drug metabolites. Psychopharmacology Berl 92 68–72 Occurrence Handle10.1007/BF00215481 Occurrence Handle1:CAS:528:DyaL2sXksFWrsL4%3D Occurrence Handle2885882
PJ Norris JP Hardwick PC Emson (1996) ArticleTitleRegional distribution of cytochrome P450 2D1 in the rat central nervous system. J Comp Neurol 366 244–258 Occurrence Handle10.1002/(SICI)1096-9861(19960304)366:2<244::AID-CNE5>3.0.CO;2-5 Occurrence Handle1:CAS:528:DyaK28XitVyju7w%3D Occurrence Handle8698885
V Ravindranath S Bhamre SV Bhagwat HK Anandatheerthavarada SK Shankar PS Tirumalai (1995) ArticleTitleXenobiotic metabolism in brain. Toxicol Lett 82–83 633–638 Occurrence Handle8597120
B Schilter CJ Omiecinski (1993) ArticleTitleRegional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 44 990–996 Occurrence Handle1:CAS:528:DyaK2cXltVOmsg%3D%3D Occurrence Handle8246922
OZ Sellinger RA Hiatt (1968) ArticleTitleCerebral lysosomes. IV. The regional and intracellular distribution of arylsulfatase and evidence for two populations of lysosomes in rat brain. Brain Res 7 191–200 Occurrence Handle10.1016/0006-8993(68)90097-8 Occurrence Handle1:CAS:528:DyaF1cXosFChtg%3D%3D Occurrence Handle5638866
L Sklair-Tavron WX Shi SB Lane HW Harris BS Bunney EJ Nestler (1996) ArticleTitleChronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 93 11202–11207 Occurrence Handle10.1073/pnas.93.20.11202 Occurrence Handle1:CAS:528:DyaK28XmtVOqs7k%3D Occurrence Handle8855333
T Sunderland BM Cohen (1987) ArticleTitleBlood to brain distribution of neuroleptics. Psychiatry Res 20 299–305 Occurrence Handle10.1016/0165-1781(87)90090-4 Occurrence Handle1:CAS:528:DyaL2sXktlamur0%3D Occurrence Handle2885876
H Tokunaga K Kudo T Imamura N Jitsufuchi Y Ohtsuka N Ikeda (1997) ArticleTitlePlasma concentrations of antipsychotic drugs in psychiatric inpatients. Nippon Hoigaku Zasshi 51 417–422 Occurrence Handle1:STN:280:DyaK1c3gsleltg%3D%3D Occurrence Handle9545754
H Weigmann S Härtter C Hiemke (1998) ArticleTitleAutomated determination of clomipramine and its major metabolites in human and rat serum by high-performance liquid chromatography with on-line column-switching. J Chromatogr B Biomed Sci Appl 710 227–233 Occurrence Handle10.1016/S0378-4347(98)00129-7 Occurrence Handle1:CAS:528:DyaK1cXks1OhsLY%3D Occurrence Handle9686892
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kornhuber, J., Weigmann, H., Röhrich, J. et al. Region specific distribution of levomepromazine in the human brain. J Neural Transm 113, 387–397 (2006). https://doi.org/10.1007/s00702-005-0331-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-005-0331-3